277 related articles for article (PubMed ID: 27161860)
1. Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain.
Griffin ML; McDermott KA; McHugh RK; Fitzmaurice GM; Jamison RN; Weiss RD
Drug Alcohol Depend; 2016 Jun; 163():216-21. PubMed ID: 27161860
[TBL] [Abstract][Full Text] [Related]
2. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.
Worley MJ; Heinzerling KG; Shoptaw S; Ling W
Exp Clin Psychopharmacol; 2015 Dec; 23(6):428-35. PubMed ID: 26302337
[TBL] [Abstract][Full Text] [Related]
3. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.
McDermott KA; Griffin ML; Connery HS; Hilario EY; Fiellin DA; Fitzmaurice GM; Weiss RD
J Clin Psychiatry; 2015 Feb; 76(2):189-94. PubMed ID: 25562462
[TBL] [Abstract][Full Text] [Related]
4. Using behavioral economics to predict opioid use during prescription opioid dependence treatment.
Worley MJ; Shoptaw SJ; Bickel WK; Ling W
Drug Alcohol Depend; 2015 Mar; 148():62-8. PubMed ID: 25622776
[TBL] [Abstract][Full Text] [Related]
5. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
Socias ME; Ahamad K; Le Foll B; Lim R; Bruneau J; Fischer B; Wild TC; Wood E; Jutras-Aswad D
Contemp Clin Trials; 2018 Jun; 69():21-27. PubMed ID: 29627621
[TBL] [Abstract][Full Text] [Related]
6. The multi-site prescription opioid addiction treatment study: 18-month outcomes.
Potter JS; Dreifuss JA; Marino EN; Provost SE; Dodd DR; Rice LS; Fitzmaurice GM; Griffin ML; Weiss RD
J Subst Abuse Treat; 2015 Jan; 48(1):62-9. PubMed ID: 25189089
[TBL] [Abstract][Full Text] [Related]
7. The Prescription Opioid Addiction Treatment Study: What have we learned.
Weiss RD; Rao V
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1(Suppl 1):S48-S54. PubMed ID: 28363320
[TBL] [Abstract][Full Text] [Related]
8. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.
Worley MJ; Heinzerling KG; Shoptaw S; Ling W
Addiction; 2017 Jul; 112(7):1202-1209. PubMed ID: 28164407
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.
Ellerbroek H; van den Heuvel SAS; Dahan A; Timmerman H; Kramers C; Schellekens AFA
Addict Sci Clin Pract; 2022 Sep; 17(1):47. PubMed ID: 36057608
[TBL] [Abstract][Full Text] [Related]
10. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
Feingold D; Brill S; Goor-Aryeh I; Delayahu Y; Lev-Ran S
J Affect Disord; 2018 Aug; 235():293-302. PubMed ID: 29660645
[TBL] [Abstract][Full Text] [Related]
11. No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study.
Latif ZE; Solli KK; Opheim A; Kunoe N; Benth JŠ; Krajci P; Sharma-Haase K; Tanum L
Am J Addict; 2019 Feb; 28(2):77-85. PubMed ID: 30701613
[TBL] [Abstract][Full Text] [Related]
12. Case Series of Successful Postoperative Pain Management in Buprenorphine Maintenance Therapy Patients.
Leighton BL; Crock LW
Anesth Analg; 2017 Nov; 125(5):1779-1783. PubMed ID: 29049122
[TBL] [Abstract][Full Text] [Related]
13. Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.
Wang X; Jiang H; Zhao M; Li J; Gray F; Sheng L; Li Y; Li X; Ling W; Li W; Hao W
Asia Pac Psychiatry; 2019 Mar; 11(1):e12344. PubMed ID: 30460781
[TBL] [Abstract][Full Text] [Related]
14. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Edwards RR; Samet JH
Drug Alcohol Depend; 2016 Sep; 166():26-31. PubMed ID: 27422763
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.
Weiss RD; Potter JS; Griffin ML; Provost SE; Fitzmaurice GM; McDermott KA; Srisarajivakul EN; Dodd DR; Dreifuss JA; McHugh RK; Carroll KM
Drug Alcohol Depend; 2015 May; 150():112-9. PubMed ID: 25818060
[TBL] [Abstract][Full Text] [Related]
16. Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.
Sullivan MD; Turner JA; DiLodovico C; D'Appollonio A; Stephens K; Chan YF
J Pain; 2017 Mar; 18(3):308-318. PubMed ID: 27908840
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance.
Buresh M
J Addict Med; 2018; 12(6):481-483. PubMed ID: 29944481
[TBL] [Abstract][Full Text] [Related]
18. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain.
Martel MO; Wasan AD; Jamison RN; Edwards RR
Drug Alcohol Depend; 2013 Sep; 132(1-2):335-41. PubMed ID: 23618767
[TBL] [Abstract][Full Text] [Related]
19. Impulsivity and risk for prescription opioid misuse in a chronic pain patient sample.
Vest N; Reynolds CJ; Tragesser SL
Addict Behav; 2016 Sep; 60():184-90. PubMed ID: 27156219
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.
Nielsen S; Hillhouse M; Mooney L; Ang A; Ling W
J Subst Abuse Treat; 2015 Jan; 48(1):70-6. PubMed ID: 25065489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]